CVS to boost access to Novo Nordisk’s weight loss treatment drug Wegovy
Wegovy will be the preferred GLP-1 medicine for obesity on the largest commercial template formularies for CVS Caremark, the largest Pharmacy Benefit Manager (PBM) in the US, effective July 1, 2025